Apellis Pharmaceuticals, Inc. (APLS) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Apellis Pharmaceuticals, Inc. (APLS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $5.25B, listed on NASDAQ, employing roughly 705 people, carrying a beta of -0.25 to the broader market. Apellis Pharmaceuticals, Inc. Led by Cedric Francois, public since 2017-11-09.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for APLS as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →